279 related articles for article (PubMed ID: 4339882)
1. A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.
Andén NE; Fuxe K
Br J Pharmacol; 1971 Dec; 43(4):747-56. PubMed ID: 4339882
[TBL] [Abstract][Full Text] [Related]
2. Noradrenaline synthesis and utilization: control by nerve impulse flow under normal conditions and after treatment with alpha-adrenoreceptor blocking agents.
Grabowska M; Andén NE
Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):53-8. PubMed ID: 6919
[TBL] [Abstract][Full Text] [Related]
3. Mode of action of L-DOPA on central noradrenaline mechanisms.
Andén NE; Engel J; Rubenson A
Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):1-10. PubMed ID: 4260802
[No Abstract] [Full Text] [Related]
4. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
Dolphin AC; Jenner P; Marsden CD
Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
[TBL] [Abstract][Full Text] [Related]
5. Locomotor stimulation by L-dopa: relative importance of noradrenaline receptor activation.
Andén NE; Strömbom U; Svensson TH
Psychopharmacology (Berl); 1977 Nov; 54(3):243-8. PubMed ID: 413140
[TBL] [Abstract][Full Text] [Related]
6. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
Strömbom U
Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
[TBL] [Abstract][Full Text] [Related]
7. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.
Andén NE; Grabowska M; Strömbom U
Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):43-52. PubMed ID: 6918
[TBL] [Abstract][Full Text] [Related]
8. A pharmacological study of the adrenergic mechanisms involved in the stretch reflex of the decerebrate rat.
Commissiong JW; Sedgwick EM
Br J Pharmacol; 1974 Mar; 50(3):365-74. PubMed ID: 4850262
[TBL] [Abstract][Full Text] [Related]
9. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
Andén NE; Engel J
Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
[No Abstract] [Full Text] [Related]
10. Synthesis of noradrenaline from 3,4-dihydroxyphenylalanine (DOPA) and dopamine in adrenergic nerves of mouse atrium--effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
Jonsson G; Sachs C
Acta Physiol Scand; 1970 Nov; 80(3):307-22. PubMed ID: 5486459
[No Abstract] [Full Text] [Related]
11. Evidence for inhibition of dopamine-beta-hydroxylase in vivo after sub-acute pyrazole treatment in rats.
MacDonald E; Pispa JP
Med Biol; 1977 Oct; 55(5):284-91. PubMed ID: 22792
[TBL] [Abstract][Full Text] [Related]
12. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.
Corrodi H; Fuxe K; Hamberger B; Ljungdahl A
Eur J Pharmacol; 1970 Oct; 12(2):145-55. PubMed ID: 5472868
[No Abstract] [Full Text] [Related]
13. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
Vetulani J; Reichenberg K
Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
[No Abstract] [Full Text] [Related]
14. Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity.
Dolphin A; Jenner P; Marsden CD
Pharmacol Biochem Behav; 1976 Oct; 5(4):431-9. PubMed ID: 1005491
[TBL] [Abstract][Full Text] [Related]
15. Prevention of phencyclidine-induced depression of the segmental reflex by L-3,4-dihydroxyphenylalanine in the rat spinal cord in vitro.
Carp JS; Ohno Y; Warnick JE
J Pharmacol Exp Ther; 1989 Mar; 248(3):1048-53. PubMed ID: 2495350
[TBL] [Abstract][Full Text] [Related]
16. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.
Breese GR; Traylor TD
Br J Pharmacol; 1971 May; 42(1):88-99. PubMed ID: 5580702
[TBL] [Abstract][Full Text] [Related]
17. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
Andén NE; Corrodi H; Fuxe K
J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
[No Abstract] [Full Text] [Related]
18. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
Ahlenius S
Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
[No Abstract] [Full Text] [Related]
19. Effects of 4-aminopyridine on the turnover of monoamines in the central nervous system of the rat.
Andén NE; Leander S
J Neural Transm; 1979; 44(1-2):1-12. PubMed ID: 438799
[TBL] [Abstract][Full Text] [Related]
20. Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats.
Ahlenius S; Engel J
Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):349-60. PubMed ID: 4255378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
